Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein

Journal of Experimental Medicine

Volumn 185, Issue 3, 1997, Pages 429-438

  Zhong, Guangming ^a   Romagnoli, Paola ^a   Germain, Ronald N ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; CYTOPLASM; ENDOCYTOSIS; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CYTOPLASM; ENDOPEPTIDASES; ENDOSOMES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; LEUCINE; MICE; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031046893     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.3.429     Document Type: Article

References (63)

1. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:287-299.
2. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-293.
3. Germain, R.N. 1995. Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function. Semin. Immunol. 7:361-372.
4. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell. 63:707-716.
5. Teyton, L., D. O'Sullivan, P.W. Dickson, V. Lotteau, A. Sette, P. Fink, and P.A. Peterson. 1990. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways, Nature (Lond.). 348:39-44.
6. Peters, P.J., J.J. Neefjes, V. Oorschot, H.L. Ploegh, and H.J. Geuze. 1991. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature (Lond.). 349:669-676.
7. Pieters, J., O. Bakke, and B. Dobberstein. 1993. The MHC class II-associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. J. Cell Sci. 106: 831-846.
8. Bremnes, B., T. Madsen, M. Gedde-Dahl, and O. Bakke. 1994. An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization. J. Cell Sci. 107:2021-2032.
9. Odorizzi, C.G., I.S. Trowbridge, L. Xue, C.R. Hopkins, C.D. Davis, and J.F. Collawn. 1994. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J. Cell Biol. 126:317-330.
10. Castellino, F., and R.N. Germain. 1995. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity. 1:73-88.
11. Cresswell, P., R.R. Avva, J.E. Davis, C.A. Lamb, J.M. Riberdy, and P.A. Roche. 1990. Intracellular transport and peptide binding properties ot HLA class II glycoproteins. Semin. Immunol. 2:273-280.
12. Riberdy, J.M., J.R. Newcomb, M.J. Surman, J.A. Barbosa, and P. Cresswell. 1992. HLA-DR molecules trom an antigen-processing mutant cell line are associated with invariant chain peptides. Nature (Lond.). 360:474-177.
13. Romagnoli, P., and R.N. Germain. 1994. The CLIP region of invariant chain plays a critical role in regulating MHC class II folding, transport, and peptide occupancy. J. Exp. Med. 180:1107-1113.
14. Sloan, V.S., P. Cameron, G. Porter, M. Gammon, M. Amaya, E. Mellins, and D.M. Zaller. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature (Lond.). 375:802-806.
15. Denzin, L.K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II αb dimers and facilitates peptide loading. Cell. 82:155-165.
16. Sherman, M.A., D.A. Weber, and P.E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity. 3:197-205.
17. Stockinger, B., U. Pessara, R.H. Lin, J. Habicht, M. Grez. and N. Koch. 1989. A role of Ia-associated invariant chains in antigen processing and presentation. Cell. 56:683-689.
18. Peterson, M., and J. Miller. 1992. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature (Lond.). 357:596-598.
19. Momburg, F., S. Fuchs, J. Drexler, R. Busch, M. Post, G.J. Hämmerling, and L. Adorini. 1993. Epitope-specific enhancement of antigen presentation by invariant chain. J. Exp. Med. 178:1453-1458.
20. Viville, S., J. Neefjes, V. Lotteau, A. Dierich, M. Lemeur, H. Ploegh, C. Benoist, and D. Mathis. 1993. Mice lacking the MHC class II-associated invariant chain. Cell. 72:635-648.
21. Bodmer, H., S. Viville, C. Benoist, and D. Mathis. 1994. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science (Wash. DC). 263: 1284-1286.
22. Harding, C.V., and E.R. Unanue. 1989. Antigen processing and intracellular Ia. Possible roles of endocytosis and protein synthesis in Ia function. J. Immunol. 142:12-19.
23. St. Pierre, Y., and T.H. Watts. 1990. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A. J. Immunol. 145:812-818.
24. Kakiuchi, T., M. Watanabe, N. Hozumi, and H. Nariuchi. 1990. Differential sensitivity of specific and nonspecific antigen-presentation by B cells to a protein synthesis inhibitor. J. Immunol. 145:1653-1658.
25. Pinet, V., M.S. Malnati, and E.O. Long. 1994. Two processing pathways for the MHC class II-restricted presentation ot exogenous influenza virus antigen. J. Immunol. 152:4852-4860.
26. Humbert, M., G. Raposo, P. Cosson, H. Reggio, J. Davoust, and J. Salamero. 1993. The invariant chain induces compact forms of class II molecules localized in late endosomal compartments. Eur. J. Immunol. 23:3158-3166.
27. Salamero, J., M. Humbert, P. Cosson, and J. Davoust. 1990. Mouse B lymphocyte specific endocytosis and recycling of MHC class II molecules. EMBO (Eur. Mol. Biol. Organ.) J. 9: 3489-3496.
28. Simonsen, A., F. Momburg, J. Drexler, G.J. Hämmerling, and O. Bakke. 1993. Intracellular distribution of the MHC class II molecules and the associated invariant chain (Ii) in different cell lines. Int. Immunol. 5:903-917.
29. Nabavi, N., Z. Ghogawala, A. Myer, I.J. Griffith, W.F. Wade, Z.Z. Chen, D.J. McKean, and L.H. Glimcher. 1989. Antigen presentation abrogated in cells expressing truncated Ia molecules. J. Immunol. 142:1444-1447.
30. Wade, W.F., Z.Z. Chen, R. Maki, S. McKercher, E. Palmer, J.C. Cambier, and J.H. Freed. 1989. Altered I-A protein-mediated transmembrane signaling in B cells that express truncated I-Ak protein. Proc. Natl. Acad. Sci. USA. 86:6297-6301.
31. Pinet. V., M. Vergelli, R. Martin, O. Bakke, and E.O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature (Lond.). 375:603-606.
32. Smiley, S.T., T.M. Laufer, D. Lo, L.H. Glimcher, and M.J. Grusby. 1995. Transgenic mice expressing MHC class II molecules with truncated Aβ cytoplasmic domains reveal signaling-independent defects in antigen presentation. Int. Immunol. 7:665-677.
33. Sercarz, E.E., P.V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-766.
34. Bonnerot, C., M.S. Marks, P. Cosson, E.J. Robertson, E.K. Bikoff, R.N. Germain, and J.S. Bonifacino. 1994. Association with BiP and aggregation of class II molecules synthesized in the absence of invariant chain. EMBO (Eur. Mol. Biol. Organ.) J. 13:934-944.
35. Miller, J., and R.N. Germain. 1986. Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain. J. Exp. Med. 164:1478-1489.
36. Engel, I., T.H.M. Ottenhoff, and R.D. Klausner. 1992. High-efficiency expression and solubilization of functional T cell antigen receptor heterodimers. Science (Wash. DC). 256:1318-1321.
37. Higuchi, R. 1989. Using PCR to engineer DNA. In PCR Technology. H. Erlich, editor. Stockton Press, New York.
38. Layet, C., and R.N. Germain. 1991. Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex AαAβ dimers from the endoplasmic reticulum/cis-Golgi compartment. Proc. Natl. Acad. Sci. USA. 88:2346-2350.
39. Hahn, W.C., E. Menzin, T. Saito, R.N. Germain, and B.E. Bierer. 1993. The complete sequences of plasmids pFNeo and pMH-Neo: convenient expression vectors for high-level expression of eukaryotic genes in hematopoietic cell lines. Gene (Amst.). 127:267-268.
40. Hämmerling, G.J., H. Lemke, U. Hämmerling, C. Hohmann, R. Wallich, and K. Rajewsky. 1978. Monoclonal antibodies against murine cell surface antigens: anti-H-2, anti-Ia and anti-T cell antibodies. Curr. Top. Microbiol. Immunol. 81: 100-106.
41. Koch, N., S. Koch, and G.J. Hämmerling. 1982. Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody. Nature (Lond.). 299:644-645.
42. Reis e Sousa, C., and R.N. Germain. 1995. MHC class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182: 841-852.
43. Roche, P.A., C.L. Teletski, E. Stang, O. Bakke, and E.O. Long. 1993. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc. Natl. Acad. Sci. USA. 90:8581-8585.
44. Harding, C.V., D.S. Collins, J.W. Slot, H.J. Geuze, and E.R. Unanue. 1991. Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells. Cell. 64: 393-401.
45. Collins, D.S., E.R. Unanue, and C.V. Harding. 1991. Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J. Immunol. 147:4054-4059.
46. Jackson, M.R., T. Nilsson, and P.A. Peterson. 1990. Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO (Eur. Mol. Biol. Organ.) J. 9:3153-3162.
47. Romagnoli, P., C. Layet, J. Yewdell, O. Bakke, and R.N. Germain. 1993. Relationship between invariant chain expression and MHC Class II transport into early and late endocytic compartments. J. Exp. Med. 177:583-596.
48. Harding, C.V., and H.J. Geuze. 1993. Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment. J. Immunol. 151:3988-3998.
49. Tulp, A., D. Verwoerd, B. Dobberstein, H.L. Ploegh, and J. Pieters. 1994. Isolation and characterization of the intracellular MHC class II compartment. Nature (Lond.). 369:120-126.
50. West, M.A., J.M. Lucocq, and C. Watts. 1994. Antigen processing and class II MHC peptide-loading in human B-lymphoblastoid cells. Nature (Lond.). 369:147-151.
51. Qiu, Y., X. Xu, A. Wandinger-Ness, D.P. Dalke, and S.K. Pierce. 1994. Separation of subcellular compartments containing distinct functional forms of MHC class II. J. Cell Biol. 125:595-605.
52. Frosch, S., U. Bonifas, and A.B. Reske-Kunz. 1993. The capacity of bone marrow-derived macrohpages to process bovine insulin is regulated by lymphokines. Int. Immunol. 5: 1551-1558.
53. Mellman, I. 1990. Endocytosis and antigen processing. Semin. Immunol. 2:229-237.
54. Letourneur, F., and R.D. Klausner. 1992. A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell. 69: 1143-1157.
55. Verhey, K.J., J.I. Yeh, and M.J. Birnbaum. 1995. Distinct signals in the GLUT4 glucose transporter for internalization and for targeting to an insulin-responsive compartment. J. Cell Biol. 130:1071-1079.
56. Marks, M.S., P.A. Roche, E. van Donselaar, L. Woodruff, P.J. Peters, and J.S. Bonifacino. 1995. A lysosomal targeting signal in the cytoplasmic tail of the β chain directs HLA-DM to MHC class II compartments. J. Cell Biol. 131:351-369.
57. Harding, C.V., R.W. Roof, P.M. Allen, and E.R. Unanue. 1991. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA. 88:2740-2744.
58. Sadegh-Nasseri, S., L.J. Stern, D.C. Wiley, and R.N. Germain. 1994. MHC class II function preserved by low-affinity peptide interactions preceding stable binding, Nature (Lond.). 370:647-650.
59. k form and dissociate rapidly at neutral pH . J. Immunol. 154:5216-5227.
60. Smiley, S.T., A.Y. Rudensky, L.H. Glimcher, and M.J. Grusby. 1996. Truncation of the class II β-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes. Proc. Natl. Acad. Sci. USA. 93:241-244.
61. Urban, R.G., R.M. Chicz, and J.L. Strominger. 1994. Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH. J. Exp. Med. 180: 751-755.
62. Doms, R.W. 1993. Protein conformational changes in virus-cell fusion. Methods Enzymol. 221:61-72.
63. Kabat, E.A., T.T. Wu, H.M. Perry, K.S. Gottesman, and C. Foeller. 1991. Sequences of proteins of immunological interest. U.S. Department of Health and Human Services.